TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Date of occurrence of the last patient
Endpoint domain: Mortality/survival
Primary endpoint: Distance travelled by the forceps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: BCVA and CRT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SVI (Stroke Volume Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Saliva secretion reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standing pulse rate decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Homeostasis model assessment of β‐cell function (HOMA‐B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Handgrip strength (HG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DUS maturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical maturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: presence or absence of a response to treatment (oxygenation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: muscle excitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: neuromuscular efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with convenience of home infusions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Costs per infusion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fewer medication days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving optimal GDMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell doubling rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SFA endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: calf microvascular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: CPM values during daily activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from TLR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: ball drop/catch task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SDMT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean macular central thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: restriction of daily life activity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: failure to grow/weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgery
Endpoint domain: Adverse events/effects
Primary endpoint: HIC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total hospitalization expenses
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: SF-MPQ2
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maths test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mononuclear inflammatory cells in mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: spatial accuracy in pattern execution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self‐controlled time for watching instructions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening heart failure events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improved maternal outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: QALY benefits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Use of safety behaviours
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Exposure to violence
Endpoint domain: Adverse events/effects
Endpoint subdomain: null
Primary endpoint: high-contrast CDVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: low-contrast CDVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight loss percentage on the day of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer-specific death
Endpoint domain: Mortality/survival
Primary endpoint: mean change in body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dose to 95% of the PTV (D95)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OARs constraints met
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved balance parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver Inflammation Fibrosis score (LIF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: iron-corrected T1 (cT1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: clinical improvement over 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: joint progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Academic scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: composite primary outcome of death, LOS or NEC
Endpoint domain: Mortality/survival
Primary endpoint: sense of control of drinking behaviour
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 5y overall survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: plasma kynurenine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma quinolinic acid concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percent change in modified Eczema Area and Severity Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in stereotypy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in hyperactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: night wakening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of END
Endpoint domain: Mortality/survival
Primary endpoint: median fetal C-peptide level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ICIQ-OAB score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall frequency and nocturia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pad test group shift
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of any grade ORN (ORNI-IV)
Endpoint domain: Adverse events/effects
Primary endpoint: eGDR as a thrombotic risk indicator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medical supervision rating during internship
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Guidance based on learning objectives rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preparation of wards and duty areas rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Desensitization rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in immune markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total vascular events prevented
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Decreased DTC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased stride length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased cadence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smile index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum duration of the initial rise of the smile index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of filler words
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CELF score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGI-I rating of improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean number of correct assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decisional certainty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 14-day clinical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-score for total hip BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and joint outcomes
Primary endpoint: use of adaptive coping strategies
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction of clinical pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone repair rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved awareness of breast cancer symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite outcome scores
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life (Qol) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Low anterior resection syndrome score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: numerical rating scale score for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of urinary C-terminal telopeptide of type II collagen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Achieving target dose of sacubitril/valsartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart failure rehospitalization
Endpoint domain: Mortality/survival
Primary endpoint: mean weekly number of cataplexy attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour urine volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: tooth bleaching sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative abundance of Bifidobacterium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-voiding flow time (PPFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Time in Range (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Time Below Range (TBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Time Above Range (TAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in slow-wave sleep (SWS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in growth hormone (GH) release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cost for the 10-day period
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of participation in RCT
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: periprocedural haemoglobin level decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: rate of complete ST-segment recovery post-PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CRP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Length of sick leave
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Overweight or obesity prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tear flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Controlled BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Fugl-Meyer Assessment of the Upper Extremity (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical benefit from taxane treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of drug-target engagement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: attentional bias towards neutral faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores in breastfeeding mothers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Milk transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritive sucking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of patent ductus arteriosus
Endpoint domain: Adverse events/effects
Primary endpoint: Desaturation during surfactant administration
Endpoint domain: Adverse events/effects
Primary endpoint: Mean absolute percentage error of blood glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain level associated with jet injection
Endpoint domain: Adverse events/effects
Primary endpoint: Serum levels of IL‐17
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: return to function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Circulating C-reactive protein concentrations decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Postprandial glucose responses reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bone union of the osteotomy gap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: external-cause maternal mortality
Endpoint domain: Mortality/survival
Primary endpoint: preventable-cause child mortality
Endpoint domain: Mortality/survival
Primary endpoint: Self-care maintenance, monitoring, and confidence
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Role limitations due to physical health and emotional problems
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: gait variables and lower-limb performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative NRS pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total analgesic requirement (tramadol consumption)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in plantar pressure at the forefoot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GOALS bimanual dexterity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incremental net monetary benefit per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Healthcare budget impact over 5 years
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: TG reduction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma interleukin-2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NOSE score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accumulate recurrence-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Success rate after the last SWL session
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median total anesthesia time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Transition Readiness Assessment Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: neonatal skinfold thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Availability of combination treatment for vitiligo
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Bioequivalence of acetylsalicylic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence of clopidogrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CFU/cm² counts after antiseptic application
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of energy brought from highly processed foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive throughput
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of IVP piperacillin/tazobactam
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total entheseal inflammation score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total structural damage score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trait anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CDAD events averted
Endpoint domain: Mortality/survival
Primary endpoint: Death averted
Endpoint domain: Mortality/survival
Primary endpoint: Mean change in PSMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emotionality problems scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical progression to hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity (NPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calf muscle extensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: false alarm threshold for facial discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weekly physical activity (PA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute increase in systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Duration of second and third stages of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNS toxicity grade 2 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Fasting lipids improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Virological suppression at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Xenograft particles contact percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Referrals for obstetric haemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: quadriceps muscle mass increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LFI decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: E-RS:COPD scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant retention rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dose goal attainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IMI Interest and Enjoyment score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of pigment spots
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: balance for most painful knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sebum production reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of C. rectus-positive individuals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: proportions of subjects achieving 5% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol recovery trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Improvement in HDRS‐22 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uncontrolled eating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: emotional eating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing